Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioCare Systems, Inc. was a medical technology company primarily focused on the development and commercialization of non-invasive diagnostic tools for early cancer detection and pain management. The company's flagship technology, LumiScan, was a non-ionizing optical imaging system designed to assist in the detection of breast cancer by measuring light transmission through tissue. Additionally, the company marketed the Bio-Pulse, a device intended for non-invasive pain relief. BioCare Systems aimed to provide safer, more comfortable alternatives to traditional diagnostic and therapeutic procedures, though the company has since ceased active operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioCare Systems.